What Happens to Refractory or Intolerant Chronic Myeloid Leukemia Patients without Access to Clinical Trials?

Autor:	Guilherme Bosi, Marco Abkalil, Lucia Mariano da Rocha Silla, Camila Bender, Laura Fogliatto, Kamila Castro Grokoski, Tito Vanelli Costa, Mariana Pinto
Rok vydání:	2017
Předmět:	Clinical trial Oncology Cancer Research medicine.medical_specialty Refractory business.industry Internal medicine medicine Myeloid leukemia Hematology business
Zdroj:	Clinical Lymphoma Myeloma and Leukemia. 17:S317-S318
ISSN:	2152-2650
DOI:	10.1016/j.clml.2017.07.120
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::294ee14342bdd3150b184439c5cee3c5 https://doi.org/10.1016/j.clml.2017.07.120 Zobrazit plný text záznamu Full Text from ScienceDirect